Loading viewer...
investor_presentation
Format: PDF investor_presentation
4th Quarter Supplemental Information January 20, 2022 1
Supplemental Information
1Specific Industry Summary
As of December 31, 2021
(1) Amounts exclude PPP loans and net deferred fees/costs
(2) Criticized includes all performing and non- performing loans risk rated Special Mention, Substandard and Doubtful
(3) Services industry includes, but is not limited to: Landscaping, Computer Services, Day Care, Community Housing and Dry Cleaning
2($ in millions) Loans with Accruing Loans
Total Balance A ctive Payment 30+ Days Non-Performing % of Portfolio PPP
Industry Commitments(1)Outstanding(1)Accommodation Past Due Loans Criticized(2)Loans
Hotels $389 $382 $0 0.00% 2.05% 9% $6
Restaurants $174 $165 $0 0.05% 0.71% 6% $42
Services(3)$413 $248 $0 0.15% 1.51% 4% $23
CRE Investment- Office $846 $785 $0 0.00% 0.01% 0% $0
CRE Investment- Retail $1,429 $1,371 $0 0.01% 0.04% 0% $0
CRE Investment- Multifamily $729 $630 $0 0.00% 0.05% 0% $0Allowance for Credit Losses – Q4 2021 Change
•Slight in crease in Q4 2021 ACL was mainly driven by the growth in loan portfolio balances in combination with the
quarterly updates to qualitative adjustments. These increases were partially offset by continued improvement in projected
near-term economic variables used in the allowance for credit losses models .
$107.9 $109.1 ($1.1 )$4.3 $4.1
ACL 9/30/21 Change in individual
reservesChange in qualitative
factorsChange in portfolio
balances and mixChange in economic
forecastChange in other factors ACL 12/31/21Allowance for Credit Losses – Full Year Change
•During 2021, ACL declined by $56.3 million primarily driven by significant improvement in economic conditions during the
year. This decline was partially offset by an increase in qualitative factors mainly related to the Company’s exposure to
certain higher risk industry segments, as well as growth in the loan portfolio.
$109.1 ($5.1 )$19.6 $5.2
ACL 12/31/20 Change in individual
reservesChange in qualitative
Preview truncated — download the full document for the complete content.
investor_presentation
27 Pages
BEST Inc.
Regeneron Pharmaceuticals Investor Presentation — February 2021
investor_presentationinvestor_presentation
28 Pages
Regeneron Pharmaceuticals, Inc.
investor_presentation
Xanadu Mining
investor_presentation
RxSight